PCM
PTEN icon

Prelude Capital Management’s Patterson-UTI PTEN Stock Holding History

Prelude Capital Management’s Portfolio PTEN Stock Details PTEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-50,000
Closed -$428K – 2182
2019
Q3 		$428K Buy
+50,000
New +$490K 0.02% 565

Other funds holding PTEN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's PTEN Position: Q4 2025 in Review

Prelude Capital Management sold out of Patterson-UTI (PTEN) in Q4 2025, closing a stake of 42,465 shares — an estimated $220K sold.

Prelude Capital Management first reported a position in PTEN in Q2 2013 and held it in 20 quarters. The position peaked at $2.06M in Q4 2017. 372 funds tracked by Wall St. Rank hold PTEN as of Q4 2025.

  • Prelude Capital Management reported no remaining Patterson-UTI position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 42,465 Patterson-UTI shares in Q4 2025, an estimated $220K.
  • Prelude Capital Management first reported a position in Patterson-UTI in Q2 2013 and held it in 20 quarters.
  • Prelude Capital Management's Patterson-UTI position peaked at $2.06M in Q4 2017.
  • 372 funds tracked by Wall St. Rank held Patterson-UTI as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.